Free Trial
→ Elon Musk’s $1 Quadrillion AI IPO (From Brownstone Research) (Ad)tc pixel Free DOC Stock Alerts

Healthpeak Properties (DOC) Financials

Healthpeak Properties logo
$19.65 +0.15 (+0.76%)
Closing price 03:59 PM Eastern
Extended Trading
$19.59 -0.06 (-0.30%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Healthpeak Properties

Annual Income Statements for Healthpeak Properties

This table shows Healthpeak Properties' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -561 627 413 1,058 44 411 502 498 304 242 71
Consolidated Net Income / (Loss)		 -546 640 423 1,073 60 428 526 516 335 267 101
Net Income / (Loss) Continuing Operations		 153 374 423 837 175 161 138 514 335 267 101
Total Pre-Tax Income 		136 367 410 839 176 218 128 507 315 273 284
Total Revenue		 1,461 1,665 1,541 930 1,023 1,427 1,738 1,888 1,981 2,420 2,517
Net Interest Income / (Expense)		 -367 -376 -251 -251 -208 -202 -120 -150 -179 -236 -243
Total Interest Income		 112 89 56 10 9.84 17 38 23 22 45 62
Investment Securities Interest Income		 112 89 56 10 9.84 17 38 23 22 45 62
Total Interest Expense		 480 464 308 261 218 218 158 173 200 280 305
Long-Term Debt Interest Expense		 480 464 308 261 218 218 158 173 200 280 305
Total Non-Interest Income		 1,828 2,040 1,792 1,181 1,230 1,628 1,858 2,038 2,159 2,656 2,761
Service Charges on Deposit Accounts		 525 - 524 144 144 436 471 495 527 568 604
Other Non-Interest Income		 1,303 2,040 1,268 1,037 1,086 1,192 1,387 1,543 1,632 2,087 2,157
Total Non-Interest Expense		 1,347 1,420 1,464 892 953 1,491 1,581 1,716 1,759 2,385 2,303
Other Operating Expenses		 707 842 755 475 498 876 872 994 95 97 90
Depreciation Expense		 505 568 535 405 435 554 684 711 750 1,057 1,059
Impairment Charge		 108 0.00 166 11 18 43 23 7.00 -5.60 23 -0.89
Restructuring Charge		 27 9.82 7.96 1.14 1.96 18 1.84 4.85 18 133 26
Other Special Charges		 - - - - - - - - 902 1,075 1,129
Nonoperating Income / (Expense), net		 23 122 334 801 107 282 -29 335 93 238 70
Income Tax Expense		 -9.81 4.47 -1.33 -4.40 -5.48 -9.42 -3.26 -4.43 -9.62 4.35 9.28
Other Gains / (Losses), net		 6.59 11 11 -5.76 -6.33 -67 6.10 1.99 10 -1.52 -174
Net Income / (Loss) Attributable to Noncontrolling Interest		 13 12 8.47 12 15 14 21 19 30 25 31
Basic Earnings per Share		 ($1.21) $1.34 $0.88 $2.25 $0.09 $0.77 $0.93 $0.92 $0.56 $0.36 $0.10
Weighted Average Basic Shares Outstanding		 462.80M 467.20M 468.76M 470.55M 486.26M 530.56M 538.93M 538.81M 547.01M 675.68M 696.03M
Diluted Earnings per Share		 ($1.21) $1.34 $0.88 $2.24 $0.09 $0.77 $0.93 $0.92 $0.56 $0.36 $0.10
Weighted Average Diluted Shares Outstanding		 462.80M 467.40M 468.94M 475.39M 489.34M 531.06M 539.24M 539.15M 547.28M 676.23M 696.04M
Weighted Average Basic & Diluted Shares Outstanding		 463.30M 467.60M 469.30M 470.40M 505.41M 538.69M 539.30M 546.78M 547.17M 699.56M 695.04M
Cash Dividends to Common per Share		 $2.26 $2.10 $1.48 $1.48 $1.48 $1.48 $1.20 $1.20 $1.20 $1.20 $1.22

Quarterly Income Statements for Healthpeak Properties

This table shows Healthpeak Properties' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 64 71 6.48 146 86 4.40 42 32 -117 114 193
Consolidated Net Income / (Loss)		 69 75 11 153 93 11 50 39 -110 122 200
Net Income / (Loss) Continuing Operations		 69 75 11 153 93 11 50 39 -110 122 200
Total Pre-Tax Income 		67 60 22 155 99 -3.23 54 40 65 125 196
Total Revenue		 506 501 546 621 626 627 630 619 629 639 666
Net Interest Income / (Expense)		 -45 -48 -55 -67 -60 -54 -57 -59 -61 -66 -73
Total Interest Income		 5.36 4.98 5.75 7.83 14 17 16 16 16 15 14
Investment Securities Interest Income		 5.36 4.98 5.75 7.83 14 17 16 16 16 15 14
Total Interest Expense		 51 53 61 75 74 71 73 75 77 81 87
Long-Term Debt Interest Expense		 51 53 61 75 74 71 73 75 77 81 87
Total Non-Interest Income		 551 549 601 688 686 681 687 679 690 705 739
Service Charges on Deposit Accounts		 134 136 139 141 143 146 149 149 150 156 200
Other Non-Interest Income		 417 412 462 547 543 535 538 530 540 549 538
Total Non-Interest Expense		 440 443 605 591 591 598 570 577 577 580 660
Other Operating Expenses		 256 246 267 301 303 301 26 297 312 -818 25
Depreciation Expense		 185 189 219 283 280 274 269 266 262 262 290
Impairment Charge		 -0.55 -5.45 11 -0.55 0.44 12 -3.56 3.50 -0.05 -0.78 -2.28
Restructuring Charge		 0.04 14 107 7.76 7.13 11 5.53 10 2.42 7.35 24
Other Special Charges		 - - - - - - 273 - - - 324
Nonoperating Income / (Expense), net		 1.48 2.60 82 126 63 -33 -6.13 -3.06 13 66 190
Income Tax Expense		 0.79 -12 14 2.73 1.94 -14 2.08 2.38 -1.21 6.03 0.25
Other Gains / (Losses), net		 2.10 3.56 2.38 0.05 -3.83 -0.11 -2.15 1.75 -176 2.71 4.27
Net Income / (Loss) Attributable to Noncontrolling Interest		 4.61 4.61 4.70 6.88 7.06 6.27 7.70 7.46 7.41 7.95 6.17
Basic Earnings per Share		 $0.12 $0.13 $0.01 $0.21 $0.12 $0.02 $0.06 $0.05 ($0.17) $0.16 $0.28
Weighted Average Basic Shares Outstanding		 547.06M 547.01M 600.90M 702.38M 699.35M 675.68M 699.07M 695.19M 694.93M 696.03M 695.16M
Diluted Earnings per Share		 $0.12 $0.13 $0.01 $0.21 $0.12 $0.02 $0.06 $0.05 ($0.17) $0.16 $0.28
Weighted Average Diluted Shares Outstanding		 547.33M 547.28M 601.19M 703.27M 700.15M 676.23M 699.12M 695.19M 694.93M 696.04M 695.17M
Weighted Average Basic & Diluted Shares Outstanding		 547.07M 547.17M 703.78M 699.29M 699.44M 699.56M 694.73M 694.92M 694.95M 695.04M 689.42M
Cash Dividends to Common per Share		 $0.30 $0.30 $0.30 $0.30 $0.30 $0.30 $0.31 $0.31 $0.31 - $0.31

Annual Cash Flow Statements for Healthpeak Properties

This table details how cash moves in and out of Healthpeak Properties' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 174 -270 -55 58 45 -2.97 38 -93 42 15 353
Net Cash From Operating Activities		 1,222 1,214 847 849 846 758 795 900 956 1,070 1,252
Net Cash From Continuing Operating Activities		 1,228 1,214 847 849 846 758 795 900 956 1,070 1,252
Net Income / (Loss) Continuing Operations		 -546 640 423 1,073 60 428 526 516 335 267 101
Consolidated Net Income / (Loss)		 -546 640 423 1,073 60 428 526 516 335 267 101
Depreciation Expense		 511 573 535 549 660 697 684 711 750 1,057 1,059
Amortization Expense		 20 20 15 13 11 -72 -85 -92 -97 -91 -104
Non-Cash Adjustments to Reconcile Net Income		 1,296 -54 -105 -833 93 -404 -356 -354 -114 -208 90
Changes in Operating Assets and Liabilities, net		 -53 35 -20 46 22 109 26 119 83 45 106
Net Cash From Investing Activities		 -1,660 -429 1,246 1,829 -1,449 -1,008 531 -876 -577 -114 -1,035
Net Cash From Continuing Investing Activities		 -1,660 -429 1,246 1,829 -1,449 -1,008 531 -876 -577 -114 -1,035
Purchase of Property, Leasehold Improvements and Equipment		 -84 -91 -115 -106 -109 -94 -111 -109 -114 -116 -134
Purchase of Investment Securities		 -2,308 -1,246 -1,011 -587 -2,326 -2,441 -2,137 -1,072 -855 -718 -1,435
Sale and/or Maturity of Investments		 628 232 2,335 2,528 514 1,509 2,742 291 371 876 506
Other Investing Activities, net		 31 28 37 26 382 19 38 13 21 -156 29
Net Cash From Financing Activities		 614 -1,054 -2,148 -2,621 647 246 -1,289 -117 -337 -941 136
Net Cash From Continuing Financing Activities		 614 -1,054 -2,148 -2,621 647 246 -1,289 -117 -337 -941 136
Issuance of Debt		 2,368 2,794 1,250 2,047 9,905 5,337 17,910 16,382 11,088 4,491 13,108
Issuance of Common Equity		 206 68 28 517 796 1,069 5.04 308 0.28 0.32 1.15
Repayment of Debt		 -989 -2,912 -2,670 -4,401 -9,332 -5,322 -18,448 -16,062 -10,718 -4,358 -12,002
Repurchase of Common Equity		 -8.74 -8.69 -4.79 -3.43 -5.04 -11 -13 -68 -6.52 -191 -97
Payment of Dividends		 -1,047 -980 -695 -697 -720 -787 -650 -648 -657 -795 -849
Other Financing Activities, Net		 85 -16 -56 -83 3.80 -41 -93 -29 -45 -90 -25

Quarterly Cash Flow Statements for Healthpeak Properties

This table details how cash moves in and out of Healthpeak Properties' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -47 55 -12 2.14 83 -58 -46 25 -3.55 378 728
Net Cash From Operating Activities		 253 231 153 316 318 284 279 363 315 294 261
Net Cash From Continuing Operating Activities		 253 231 153 316 318 284 279 363 315 294 261
Net Income / (Loss) Continuing Operations		 69 75 11 153 93 11 50 39 -110 122 200
Consolidated Net Income / (Loss)		 69 75 11 153 93 11 50 39 -110 122 200
Depreciation Expense		 185 189 219 283 280 274 269 266 262 262 290
Amortization Expense		 -23 -25 -24 -22 -23 -21 -26 -26 -24 -27 -25
Non-Cash Adjustments to Reconcile Net Income		 -5.44 -22 -52 -125 -61 29 3.69 2.70 155 -72 -200
Changes in Operating Assets and Liabilities, net		 29 14 -1.75 27 29 -9.50 -17 82 31 9.12 -2.85
Net Cash From Investing Activities		 -222 -216 -98 188 30 -234 -231 -210 -188 -406 -639
Net Cash From Continuing Investing Activities		 -222 -216 -98 188 30 -234 -231 -210 -188 -406 -639
Purchase of Property, Leasehold Improvements and Equipment		 -24 -47 -18 -36 -24 -39 -23 -26 -27 -58 -24
Purchase of Investment Securities		 -214 -199 -14 -139 -205 -109 -280 -202 -263 -691 -889
Sale and/or Maturity of Investments		 6.76 25 106 354 254 -89 65 9.53 95 337 265
Other Investing Activities, net		 8.56 5.66 -172 8.47 4.44 2.71 7.48 8.07 7.20 5.76 8.87
Net Cash From Financing Activities		 -77 40 -67 -502 -266 -107 -94 -129 -130 490 1,106
Net Cash From Continuing Financing Activities		 -77 40 -67 -502 -266 -107 -94 -129 -130 490 1,106
Issuance of Debt		 1,785 2,546 3,250 646 0.25 595 4,773 2,455 3,195 2,685 5,888
Issuance of Common Equity		 0.04 0.54 0.09 0.08 0.07 0.08 0.06 0.11 0.13 0.84 0.10
Repayment of Debt		 -1,691 -2,336 -3,043 -805 -26 -483 -4,619 -2,296 -3,111 -1,976 -5,321
Repurchase of Common Equity		 -0.01 -0.04 -102 -68 -20 -0.33 -25 -72 -0.02 -0.09 -1.37
Payment of Dividends		 -164 -164 -164 -211 -210 -210 -213 -212 -212 -212 -212
Other Financing Activities, Net		 -7.14 -6.74 -7.25 -63 -9.72 -9.34 -10 -2.99 -2.51 -9.05 753

Annual Balance Sheets for Healthpeak Properties

This table presents Healthpeak Properties' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 21,450 15,759 14,088 12,719 14,033 15,920 15,258 15,771 15,699 19,938 20,336
Cash and Due from Banks		 340 95 55 111 80 44 158 72 118 120 467
Restricted Cash		 46 42 27 29 13 67 53 55 51 64 70
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 11,854 11,326 10,732 10,209 8,231 11,120 12,667 13,023 13,028 15,831 16,099
Goodwill		 - - - - - - - - - 69 69
Intangible Assets		 587 480 410 305 260 520 520 418 314 817 655
Other Assets		 8,622 3,009 2,864 2,001 5,448 3,974 1,859 2,203 2,187 3,037 2,976
Total Liabilities & Shareholders' Equity		 21,450 15,759 14,088 12,719 14,033 15,920 15,258 15,771 15,699 19,938 20,336
Total Liabilities		 11,704 9,818 8,494 6,206 7,365 8,573 8,111 8,483 8,774 10,881 12,034
Short-Term Debt		 94 92 94 91 93 - 1,166 996 720 150 1,079
Other Short-Term Payables		 431 417 402 392 - 761 - - 657 - 719
Long-Term Debt		 10,975 9,097 7,786 5,477 5,909 6,298 5,004 5,502 6,156 8,566 8,769
Other Long-Term Liabilities		 204 211 211 246 1,363 1,514 1,941 1,985 1,240 2,165 1,467
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 - - - - - 57 87 106 49 2.61 160
Total Equity & Noncontrolling Interests		 9,746 5,941 5,595 6,513 6,667 7,290 7,059 7,183 6,876 9,055 8,143
Total Preferred & Common Equity		 9,344 5,548 5,301 5,944 6,085 6,734 6,515 6,655 6,350 8,401 7,500
Total Common Equity		 9,344 5,548 5,301 5,944 6,085 6,734 6,515 6,655 6,350 8,401 7,500
Common Stock		 12,113 8,667 8,696 8,876 9,689 10,714 10,639 10,896 10,953 13,547 13,463
Retained Earnings		 -2,738 -3,090 -3,371 - -3,601 -3,976 -4,121 -4,270 - - -5,953
Accumulated Other Comprehensive Income / (Loss)		 -30 -30 -24 -4.71 -2.86 -3.69 -3.15 28 19 29 -9.94
Noncontrolling Interest		 403 394 294 568 582 556 543 528 526 654 643

Quarterly Balance Sheets for Healthpeak Properties

This table presents Healthpeak Properties' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 15,604 15,603 15,699 20,542 20,180 19,970 19,938 19,816 19,810 19,582 21,616
Cash and Due from Banks		 104 63 118 102 107 180 120 71 89 91 1,171
Restricted Cash		 57 50 51 55 52 62 64 68 74 69 95
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 13,097 13,120 13,028 16,663 16,398 15,892 15,831 15,840 15,820 15,831 16,837
Goodwill		 - - - - - - - - - - 69
Intangible Assets		 364 339 314 1,160 1,076 898 817 748 677 611 758
Other Assets		 1,981 2,029 2,187 2,561 2,546 2,937 3,105 3,090 3,150 2,981 2,686
Total Liabilities & Shareholders' Equity		 15,604 15,603 15,699 20,542 20,180 19,970 19,938 19,816 19,810 19,582 21,616
Total Liabilities		 8,478 8,570 8,774 10,943 10,761 10,748 10,881 10,972 11,223 11,317 12,556
Short-Term Debt		 329 424 720 183 25 0.00 150 164 775 368 1,751
Long-Term Debt		 6,240 6,240 6,156 8,573 8,578 8,583 8,566 8,713 8,266 8,763 8,671
Other Long-Term Liabilities		 1,909 1,905 1,240 2,187 2,158 2,164 1,439 1,425 2,182 1,439 2,133
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 64 49 49 55 1.43 1.32 2.61 14 20 28 27
Total Equity & Noncontrolling Interests		 7,062 6,984 6,876 9,545 9,417 9,221 9,055 8,829 8,567 8,237 9,033
Total Preferred & Common Equity		 6,535 6,457 6,350 8,882 8,757 8,563 8,401 8,188 7,928 7,597 7,826
Total Common Equity		 6,535 6,457 6,350 8,882 8,757 8,563 8,401 8,188 7,928 7,597 7,826
Common Stock		 10,932 10,949 10,953 13,623 13,560 13,544 13,547 13,526 13,459 13,460 13,798
Accumulated Other Comprehensive Income / (Loss)		 31 37 19 39 42 -12 29 6.93 -5.02 -7.98 -0.46
Other Equity Adjustments		 -4,428 -4,529 -4,622 - -4,845 -4,969 -5,174 - -5,526 - -5,972
Noncontrolling Interest		 527 527 526 663 660 658 654 641 639 640 1,207

Annual Metrics And Ratios for Healthpeak Properties

This table displays calculated financial ratios and metrics derived from Healthpeak Properties' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 22.04% 13.96% -7.46% -39.63% 9.97% 39.48% 21.85% 8.63% 4.90% 22.18% 4.02%
EBITDA Growth		 -12.90% 29.98% -25.31% -4.12% 23.41% -24.25% 34.86% 4.50% 10.63% 14.53% 16.76%
EBIT Growth		 -56.59% 115.46% -68.74% -50.44% 83.56% -192.51% 344.16% 9.18% 29.04% -84.15% 510.13%
NOPAT Growth		 -53.55% 98.55% -68.25% -50.34% 88.28% -193.61% 339.98% 7.41% 31.83% -84.87% 499.76%
Net Income Growth		 -158.34% 217.11% -33.96% 154.00% -94.41% 613.03% 22.81% -1.81% -35.18% -20.15% -62.21%
EPS Growth		 -158.34% 210.74% -34.33% 154.55% -95.98% 755.56% 20.78% -1.08% -39.13% -35.71% -72.22%
Operating Cash Flow Growth		 -2.12% -0.66% -30.23% 0.20% -0.31% -10.36% 4.85% 13.21% 6.22% 11.95% 16.95%
Free Cash Flow Firm Growth		 102.89% 23,686.22% -70.77% -17.27% -136.11% -101.55% 147.04% -160.44% 171.89% -1,947.45% 95.70%
Invested Capital Growth		 0.47% -27.31% -10.94% -10.35% 4.88% 7.70% -2.41% 3.53% 0.11% 28.78% 2.12%
Revenue Q/Q Growth		 6.07% 42.21% -4.07% -45.70% 15.31% 84.44% 4.14% 1.53% 1.32% 5.52% 0.45%
EBITDA Q/Q Growth		 445.54% -2.68% -20.04% -5.75% 45.38% -19.01% 7.31% -1.67% 6.78% 6.58% 0.88%
EBIT Q/Q Growth		 129.40% -10.10% -65.49% -44.10% 168.54% -821.84% 25.11% -7.10% 26.48% -43.95% 15.51%
NOPAT Q/Q Growth		 145.02% -11.65% -66.10% -44.47% 170.60% -851.75% 23.31% -7.29% 31.12% -43.75% 4.52%
Net Income Q/Q Growth		 -320.48% 4,101.79% -22.00% 492.53% -92.91% 31.62% -18.28% -4.05% 23.91% -19.49% 1,100.96%
EPS Q/Q Growth		 -320.48% 2,014.29% -22.12% 522.22% -94.67% 30.51% -18.42% -4.17% 27.27% -23.40% 350.00%
Operating Cash Flow Q/Q Growth		 -0.90% -10.27% -0.74% 0.79% 0.20% 0.16% 0.66% -1.85% 2.61% 5.13% 0.85%
Free Cash Flow Firm Q/Q Growth		 101.53% 328.45% -76.60% 50.77% 34.25% -59.58% -52.84% 54.64% 9.71% 2.69% -127.90%
Invested Capital Q/Q Growth		 -3.66% -26.18% 1.16% -2.88% -3.46% -1.02% 3.41% 0.50% 0.76% -0.18% 4.33%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 44.13% 50.33% 40.62% 64.52% 72.41% 39.32% 43.52% 41.86% 44.15% 41.39% 46.46%
EBIT Margin		 7.78% 14.71% 4.97% 4.08% 6.81% -4.52% 9.05% 9.10% 11.19% 1.45% 8.51%
Profit (Net Income) Margin		 -37.40% 38.44% 27.43% 115.42% 5.87% 30.02% 30.26% 27.35% 16.90% 11.05% 4.01%
Tax Burden Percent		 -400.98% 174.23% 102.98% 128.01% 34.06% 196.73% 409.71% 101.83% 106.29% 97.85% 35.54%
Interest Burden Percent		 119.87% 149.94% 536.01% 2,209.92% 253.13% -337.81% 81.59% 295.21% 142.08% 777.64% 132.65%
Effective Tax Rate		 -7.20% 1.22% -0.32% -0.52% -3.11% -4.33% -2.54% -0.87% -3.05% 1.59% 3.27%
Return on Invested Capital (ROIC)		 0.59% 1.35% 0.54% 0.30% 0.58% -0.51% 1.20% 1.28% 1.66% 0.22% 1.15%
ROIC Less NNEP Spread (ROIC-NNEP)		 -5.84% 5.28% 4.59% 15.70% 0.38% 7.55% 7.05% 6.70% 3.25% 3.20% 0.01%
Return on Net Nonoperating Assets (RNNOA)		 -5.86% 6.81% 6.79% 17.43% 0.33% 6.62% 6.06% 5.88% 3.05% 3.13% 0.01%
Return on Equity (ROE)		 -5.27% 8.16% 7.33% 17.73% 0.91% 6.11% 7.26% 7.16% 4.71% 3.34% 1.16%
Cash Return on Invested Capital (CROIC)		 0.12% 32.97% 12.11% 11.22% -4.18% -7.93% 3.64% -2.19% 1.55% -24.94% -0.94%
Operating Return on Assets (OROA)		 0.53% 1.32% 0.51% 0.28% 0.52% -0.43% 1.01% 1.11% 1.41% 0.20% 1.06%
Return on Assets (ROA)		 -2.55% 3.44% 2.83% 8.01% 0.45% 2.86% 3.37% 3.33% 2.13% 1.50% 0.50%
Return on Common Equity (ROCE)		 -5.10% 7.74% 6.89% 16.47% 0.83% 5.59% 6.63% 6.53% 4.31% 3.09% 1.07%
Return on Equity Simple (ROE_SIMPLE)		 -5.85% 11.54% 7.97% 18.06% 0.99% 6.36% 8.07% 7.76% 5.27% 3.18% 1.35%
Net Operating Profit after Tax (NOPAT)		 122 242 77 38 72 -67 161 173 228 35 207
NOPAT Margin		 8.34% 14.53% 4.99% 4.10% 7.02% -4.71% 9.28% 9.18% 11.53% 1.43% 8.24%
Net Nonoperating Expense Percent (NNEP)		 6.43% -3.93% -4.05% -15.40% 0.20% -8.06% -5.85% -5.42% -1.59% -2.99% 1.15%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 92.22% 85.29% 95.03% 95.92% 93.19% 104.52% 90.95% 90.90% 88.81% 98.55% 91.49%
Earnings before Interest and Taxes (EBIT)		 114 245 77 38 70 -64 157 172 222 35 214
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 645 838 626 600 741 561 756 790 874 1,002 1,169
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.18 1.80 1.60 1.62 2.16 1.96 2.51 1.77 1.58 1.66 1.48
Price to Tangible Book Value (P/TBV)		 1.26 1.98 1.73 1.71 2.25 2.12 2.72 1.89 1.66 1.84 1.64
Price to Revenue (P/Rev)		 7.55 6.01 5.50 10.37 12.83 9.24 9.39 6.25 5.07 5.77 4.41
Price to Earnings (P/E)		 0.00 15.98 20.51 9.11 298.30 32.05 32.50 23.70 32.99 57.60 157.56
Dividend Yield		 9.53% 9.96% 8.20% 7.21% 5.58% 6.05% 3.96% 5.47% 6.54% 6.01% 7.63%
Earnings Yield		 0.00% 6.26% 4.88% 10.97% 0.34% 3.12% 3.08% 4.22% 3.03% 1.74% 0.63%
Enterprise Value to Invested Capital (EV/IC)		 1.06 1.29 1.23 1.29 1.55 1.46 1.72 1.36 1.25 1.30 1.17
Enterprise Value to Revenue (EV/Rev)		 15.14 11.69 10.75 16.82 19.18 14.00 13.18 9.96 8.74 9.57 8.43
Enterprise Value to EBITDA (EV/EBITDA)		 34.30 23.22 26.46 26.07 26.48 35.61 30.29 23.79 19.80 23.11 18.15
Enterprise Value to EBIT (EV/EBIT)		 194.53 79.43 216.31 412.22 281.56 0.00 145.64 109.45 78.13 659.00 99.02
Enterprise Value to NOPAT (EV/NOPAT)		 181.47 80.41 215.61 410.07 273.08 0.00 142.03 108.50 75.82 669.66 102.36
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.10 16.03 19.55 18.43 23.18 26.34 28.81 20.89 18.11 21.62 16.95
Enterprise Value to Free Cash Flow (EV/FCFF)		 887.61 3.28 9.56 10.92 0.00 0.00 46.71 0.00 81.25 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.14 1.55 1.41 0.85 0.90 0.86 0.86 0.89 0.99 0.96 1.19
Long-Term Debt to Equity		 1.13 1.53 1.39 0.84 0.89 0.86 0.70 0.75 0.89 0.95 1.06
Financial Leverage		 1.00 1.29 1.48 1.11 0.88 0.88 0.86 0.88 0.94 0.98 1.07
Leverage Ratio		 2.06 2.37 2.59 2.21 2.03 2.14 2.15 2.15 2.21 2.23 2.32
Compound Leverage Factor		 2.47 3.56 13.87 48.93 5.14 -7.22 1.76 6.35 3.15 17.34 3.08
Debt to Total Capital		 53.18% 60.73% 58.48% 46.09% 47.37% 46.15% 46.33% 47.13% 49.82% 49.04% 54.26%
Short-Term Debt to Total Capital		 0.45% 0.61% 0.70% 0.75% 0.73% 0.00% 8.76% 7.22% 5.22% 0.84% 5.94%
Long-Term Debt to Total Capital		 52.72% 60.12% 57.78% 45.34% 46.64% 46.15% 37.58% 39.91% 44.61% 48.20% 48.31%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.93% 2.60% 2.18% 4.70% 4.60% 4.50% 4.74% 4.60% 4.16% 3.69% 4.42%
Common Equity to Total Capital		 44.89% 36.66% 39.34% 49.21% 48.03% 49.35% 48.93% 48.27% 46.01% 47.27% 41.32%
Debt to EBITDA		 17.17 10.97 12.59 9.28 8.11 11.23 8.16 8.22 7.86 8.70 8.42
Net Debt to EBITDA		 16.57 10.80 12.46 9.05 7.98 11.03 7.88 8.06 7.67 8.52 7.96
Long-Term Debt to EBITDA		 17.02 10.86 12.44 9.13 7.98 11.23 6.61 6.96 7.04 8.55 7.50
Debt to NOPAT		 90.83 37.98 102.59 145.97 83.57 -93.68 38.24 37.50 30.10 252.14 47.50
Net Debt to NOPAT		 87.66 37.41 101.52 142.30 82.27 -92.02 36.93 36.77 29.36 246.81 44.91
Long-Term Debt to NOPAT		 90.05 37.60 101.36 143.59 82.28 -93.68 31.02 31.75 26.95 247.80 42.30
Noncontrolling Interest Sharing Ratio		 3.20% 5.08% 5.96% 7.12% 8.73% 8.53% 8.59% 8.76% 8.50% 7.70% 8.40%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 25 5,926 1,732 1,433 -517 -1,043 491 -297 213 -3,938 -169
Operating Cash Flow to CapEx		 10,977.68% 0.00% 734.90% 799.21% 777.33% 805.80% 713.35% 829.66% 841.79% 924.56% 934.64%
Free Cash Flow to Firm to Interest Expense		 0.05 12.76 5.63 5.48 -2.38 -4.78 3.11 -1.71 1.06 -14.04 -0.55
Operating Cash Flow to Interest Expense		 2.55 2.61 2.75 3.25 3.89 3.47 5.03 5.21 4.77 3.82 4.10
Operating Cash Flow Less CapEx to Interest Expense		 2.53 3.81 2.38 2.84 3.39 3.04 4.33 4.58 4.21 3.40 3.66
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.07 0.09 0.10 0.07 0.08 0.10 0.11 0.12 0.13 0.14 0.13
Fixed Asset Turnover		 0.13 0.14 0.14 0.09 0.11 0.15 0.15 0.15 0.15 0.17 0.16
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 20,815 15,131 13,475 12,080 12,670 13,645 13,316 13,786 13,801 17,774 18,150
Invested Capital Turnover		 0.07 0.09 0.11 0.07 0.08 0.11 0.13 0.14 0.14 0.15 0.14
Increase / (Decrease) in Invested Capital		 97 -5,685 -1,655 -1,395 589 976 -329 470 15 3,973 377
Enterprise Value (EV)		 22,115 19,456 16,562 15,642 19,612 19,976 22,914 18,802 17,319 23,149 21,223
Market Capitalization		 11,030 10,010 8,470 9,646 13,121 13,176 16,325 11,798 10,037 13,961 11,110
Book Value per Share		 $20.09 $11.85 $11.30 $12.65 $12.29 $12.51 $12.09 $12.38 $11.61 $12.01 $10.79
Tangible Book Value per Share		 $18.83 $10.83 $10.43 $12.00 $11.77 $11.54 $11.12 $11.60 $11.03 $10.84 $9.75
Total Capital		 20,815 15,131 13,475 12,080 12,670 13,645 13,316 13,786 13,801 17,774 18,150
Total Debt		 11,069 9,189 7,880 5,568 6,002 6,298 6,170 6,498 6,876 8,716 9,848
Total Long-Term Debt		 10,975 9,097 7,786 5,477 5,909 6,298 5,004 5,502 6,156 8,566 8,769
Net Debt		 10,682 9,053 7,798 5,428 5,908 6,187 5,958 6,371 6,707 8,532 9,310
Capital Expenditures (CapEx)		 11 -556 115 106 109 94 111 109 114 116 134
Net Nonoperating Expense (NNE)		 668 -398 -346 -1,035 12 -495 -365 -343 -106 -233 106
Net Nonoperating Obligations (NNO)		 11,069 9,189 7,880 5,568 6,002 6,298 6,170 6,498 6,876 8,716 9,848
Total Depreciation and Amortization (D&A)		 531 593 549 562 671 625 599 619 653 966 955
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.11) $1.34 $0.88 $2.25 $0.09 $0.77 $0.93 $0.92 $0.56 $0.36 $0.10
Adjusted Weighted Average Basic Shares Outstanding		 506.09M 467.20M 468.76M 470.55M 486.26M 530.56M 538.93M 538.81M 547.01M 675.68M 696.03M
Adjusted Diluted Earnings per Share		 ($1.11) $1.34 $0.88 $2.24 $0.09 $0.77 $0.93 $0.92 $0.56 $0.36 $0.10
Adjusted Weighted Average Diluted Shares Outstanding		 506.09M 467.40M 468.94M 475.39M 489.34M 531.06M 539.24M 539.15M 547.28M 676.23M 696.04M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.09 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 509.08M 468.18M 469.44M 477.77M 505.41M 538.69M 539.30M 546.78M 547.17M 699.56M 695.04M
Normalized Net Operating Profit after Tax (NOPAT)		 175 252 176 35 63 -2.23 128 129 164 188 1,323
Normalized NOPAT Margin		 11.95% 15.12% 11.40% 3.76% 6.11% -0.16% 7.34% 6.81% 8.26% 7.76% 52.57%
Pre Tax Income Margin		 9.33% 22.06% 26.64% 90.17% 17.24% 15.26% 7.39% 26.86% 15.90% 11.29% 11.29%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.24 0.53 0.25 0.15 0.32 -0.30 1.00 0.99 1.11 0.13 0.70
NOPAT to Interest Expense		 0.25 0.52 0.25 0.15 0.33 -0.31 1.02 1.00 1.14 0.12 0.68
EBIT Less CapEx to Interest Expense		 0.21 1.73 -0.13 -0.26 -0.18 -0.73 0.29 0.37 0.54 -0.29 0.26
NOPAT Less CapEx to Interest Expense		 0.23 1.72 -0.12 -0.26 -0.17 -0.74 0.32 0.37 0.57 -0.29 0.24
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -191.55% 153.07% 164.43% 64.92% 1,198.99% 183.79% 123.61% 125.49% 196.27% 297.33% 840.46%
Augmented Payout Ratio		 -193.14% 154.43% 165.57% 65.24% 1,207.38% 186.25% 126.05% 138.62% 198.22% 368.67% 936.62%

Quarterly Metrics And Ratios for Healthpeak Properties

This table displays calculated financial ratios and metrics derived from Healthpeak Properties' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 695,043,997.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 695,043,997.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.29
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 6.17% 5.43% 14.22% 25.03% 23.84% 25.28% 15.49% -0.21% 0.45% 1.80% 5.63%
EBITDA Growth		 10.99% 33.49% -34.52% 32.68% 28.67% 27.92% 123.25% -2.72% -0.52% 3.62% -10.81%
EBIT Growth		 21.41% 422.20% -217.04% -38.57% -46.55% -47.99% 201.93% 45.54% 49.35% 96.38% -90.73%
NOPAT Growth		 18.71% 484.97% -145.89% -38.36% -46.98% -69.59% 350.60% 39.25% 55.17% 167.03% -90.37%
Net Income Growth		 -80.82% 597.97% -91.69% 171.74% 35.08% -85.85% 347.92% -74.45% -218.45% 1,041.23% 298.80%
EPS Growth		 -81.54% 1,200.00% -95.45% 133.33% 0.00% -84.62% 500.00% -76.19% -241.67% 700.00% 366.67%
Operating Cash Flow Growth		 3.95% 11.74% -12.28% 6.17% 25.64% 22.61% 83.16% 14.95% -1.02% 3.72% -6.64%
Free Cash Flow Firm Growth		 110.84% 111.67% -1,812.59% -1,709.83% -4,882.92% -7,493.81% 114.75% 110.09% 111.34% 91.88% -353.43%
Invested Capital Growth		 -0.15% 0.11% 34.20% 31.60% 29.99% 28.78% -3.46% -2.18% -2.29% 2.12% 9.95%
Revenue Q/Q Growth		 1.89% -0.96% 8.94% 13.73% 0.92% 0.19% 0.43% -1.73% 1.58% 1.54% 4.21%
EBITDA Q/Q Growth		 3.63% -2.48% -38.78% 114.45% 0.50% -3.05% 6.84% -6.55% 2.78% 0.98% -8.03%
EBIT Q/Q Growth		 37.88% -12.85% -203.27% 149.51% 19.96% -15.20% 102.39% -29.31% 23.10% 11.50% -90.45%
NOPAT Q/Q Growth		 39.17% 5.58% -133.74% 224.34% 19.70% -39.45% 178.05% -30.91% 33.39% 4.20% -89.98%
Net Income Q/Q Growth		 22.17% 9.82% -85.18% 1,266.34% -39.27% -88.49% 369.12% -22.06% -381.52% 210.87% 63.93%
EPS Q/Q Growth		 33.33% 8.33% -92.31% 2,000.00% -42.86% -83.33% 200.00% -16.67% -440.00% 194.12% 75.00%
Operating Cash Flow Q/Q Growth		 -14.96% -8.69% -34.03% 107.26% 0.63% -10.90% -1.45% 30.08% -13.35% -6.63% -11.29%
Free Cash Flow Firm Q/Q Growth		 135.86% -37.25% -8,895.93% 8.56% 5.24% 3.00% 117.55% -37.44% 6.53% -169.44% -447.61%
Invested Capital Q/Q Growth		 0.02% 0.76% 33.00% -1.82% -1.20% -0.18% -0.30% -0.52% -1.31% 4.33% 7.34%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 44.89% 44.20% 24.84% 46.84% 46.64% 45.14% 48.02% 45.66% 46.20% 45.94% 40.55%
EBIT Margin		 13.02% 11.46% -10.86% 4.73% 5.62% 4.76% 9.59% 6.90% 8.36% 9.18% 0.84%
Profit (Net Income) Margin		 13.58% 15.05% 2.05% 24.61% 14.81% 1.70% 7.94% 6.30% -17.46% 19.07% 29.99%
Tax Burden Percent		 101.95% 125.67% 49.68% 98.28% 94.14% -329.99% 92.21% 98.40% -168.38% 97.35% 102.05%
Interest Burden Percent		 102.25% 104.53% -37.96% 529.54% 279.83% -10.83% 89.86% 92.84% 124.08% 213.42% 3,493.66%
Effective Tax Rate		 1.17% -19.74% 60.88% 1.76% 1.97% 0.00% 3.83% 6.01% -1.85% 4.82% 0.13%
Return on Invested Capital (ROIC)		 1.84% 1.97% -0.54% 0.64% 0.80% 0.51% 1.28% 0.91% 1.21% 1.22% 0.12%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.89% 2.07% -0.09% 2.27% 1.57% 0.38% 1.19% 0.90% -0.63% 1.94% 2.13%
Return on Net Nonoperating Assets (RNNOA)		 1.77% 1.95% -0.08% 2.08% 1.47% 0.37% 1.14% 0.88% -0.64% 2.07% 2.29%
Return on Equity (ROE)		 3.60% 3.92% -0.63% 2.72% 2.27% 0.88% 2.42% 1.79% 0.57% 3.29% 2.41%
Cash Return on Invested Capital (CROIC)		 1.42% 1.55% -28.52% -26.71% -25.69% -24.94% 4.40% 3.19% 3.45% -0.94% -8.63%
Operating Return on Assets (OROA)		 1.63% 1.44% -1.23% 0.57% 0.72% 0.65% 1.19% 0.86% 1.06% 1.15% 0.10%
Return on Assets (ROA)		 1.70% 1.89% 0.23% 2.99% 1.91% 0.23% 0.99% 0.79% -2.21% 2.38% 3.70%
Return on Common Equity (ROCE)		 3.29% 3.59% -0.58% 2.51% 2.10% 0.81% 2.24% 1.66% 0.53% 3.02% 2.15%
Return on Equity Simple (ROE_SIMPLE)		 4.18% 0.00% 2.38% 3.52% 3.88% 0.00% 3.74% 2.43% -0.13% 0.00% 3.20%
Net Operating Profit after Tax (NOPAT)		 65 69 -23 29 35 21 58 40 54 56 5.59
NOPAT Margin		 12.87% 13.72% -4.25% 4.65% 5.51% 3.33% 9.22% 6.48% 8.51% 8.74% 0.84%
Net Nonoperating Expense Percent (NNEP)		 -0.05% -0.10% -0.45% -1.63% -0.76% 0.13% 0.09% 0.01% 1.84% -0.71% -2.01%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 86.98% 88.54% 110.86% 95.27% 94.38% 95.24% 90.41% 93.10% 91.64% 90.82% 99.16%
Earnings before Interest and Taxes (EBIT)		 66 57 -59 29 35 30 60 43 53 59 5.60
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 227 221 136 291 292 283 303 283 291 293 270
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.42 1.58 1.09 1.51 1.81 1.66 1.72 1.50 1.74 1.48 1.45
Price to Tangible Book Value (P/TBV)		 1.49 1.66 1.25 1.72 2.03 1.84 1.89 1.64 1.89 1.64 1.62
Price to Revenue (P/Rev)		 4.68 5.07 4.72 6.08 6.77 5.77 5.62 4.75 5.28 4.41 4.45
Price to Earnings (P/E)		 38.07 32.99 50.09 46.01 50.31 57.60 50.55 72.53 0.00 157.56 51.22
Dividend Yield		 7.18% 6.54% 6.79% 6.39% 5.40% 6.01% 5.99% 7.07% 6.38% 7.63% 7.47%
Earnings Yield		 2.63% 3.03% 2.00% 2.17% 1.99% 1.74% 1.98% 1.38% 0.00% 0.63% 1.95%
Enterprise Value to Invested Capital (EV/IC)		 1.19 1.25 1.03 1.24 1.38 1.30 1.32 1.22 1.31 1.17 1.12
Enterprise Value to Revenue (EV/Rev)		 8.32 8.74 9.27 10.27 10.70 9.57 9.37 8.56 9.13 8.43 8.52
Enterprise Value to EBITDA (EV/EBITDA)		 19.87 19.80 23.64 25.51 26.11 23.11 20.08 18.46 19.73 18.15 19.13
Enterprise Value to EBIT (EV/EBIT)		 92.84 78.13 169.91 239.11 391.47 659.00 151.54 127.43 123.27 99.02 136.31
Enterprise Value to NOPAT (EV/NOPAT)		 93.39 75.82 173.11 243.40 399.21 669.66 148.01 122.50 115.32 102.36 138.74
Enterprise Value to Operating Cash Flow (EV/OCF)		 17.46 18.11 20.31 23.41 24.10 21.62 19.59 17.22 18.43 16.95 17.63
Enterprise Value to Free Cash Flow (EV/FCFF)		 83.74 81.25 0.00 0.00 0.00 0.00 29.56 37.69 37.69 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.95 0.99 0.91 0.91 0.93 0.96 1.00 1.05 1.10 1.19 1.15
Long-Term Debt to Equity		 0.89 0.89 0.89 0.91 0.93 0.95 0.99 0.96 1.06 1.06 0.96
Financial Leverage		 0.94 0.94 0.90 0.92 0.94 0.98 0.96 0.98 1.01 1.07 1.08
Leverage Ratio		 2.21 2.21 2.15 2.16 2.19 2.23 2.19 2.22 2.26 2.32 2.31
Compound Leverage Factor		 2.26 2.31 -0.82 11.45 6.12 -0.24 1.97 2.06 2.81 4.95 80.85
Debt to Total Capital		 48.66% 49.82% 47.70% 47.74% 48.21% 49.04% 50.09% 51.29% 52.49% 54.26% 53.50%
Short-Term Debt to Total Capital		 3.10% 5.22% 1.00% 0.14% 0.00% 0.84% 0.93% 4.40% 2.12% 5.94% 8.99%
Long-Term Debt to Total Capital		 45.56% 44.61% 46.70% 47.60% 48.21% 48.20% 49.17% 46.89% 50.37% 48.31% 44.51%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 4.20% 4.16% 3.91% 3.67% 3.70% 3.69% 3.70% 3.74% 3.84% 4.42% 6.33%
Common Equity to Total Capital		 47.14% 46.01% 48.39% 48.59% 48.09% 47.27% 46.21% 44.97% 43.67% 41.32% 40.17%
Debt to EBITDA		 8.14 7.86 10.90 9.84 9.13 8.70 7.60 7.79 7.88 8.42 9.17
Net Debt to EBITDA		 8.00 7.67 10.71 9.65 8.88 8.52 7.48 7.65 7.74 7.96 8.06
Long-Term Debt to EBITDA		 7.62 7.04 10.68 9.81 9.13 8.55 7.46 7.12 7.56 7.50 7.63
Debt to NOPAT		 38.25 30.10 79.83 93.83 139.67 252.14 56.00 51.68 46.04 47.50 66.51
Net Debt to NOPAT		 37.60 29.36 78.39 92.09 135.73 246.81 55.13 50.75 45.23 44.91 58.43
Long-Term Debt to NOPAT		 35.82 26.95 78.16 93.56 139.67 247.80 54.97 47.25 44.18 42.30 55.33
Noncontrolling Interest Sharing Ratio		 8.72% 8.50% 7.92% 7.57% 7.60% 7.70% 7.45% 7.33% 7.59% 8.40% 10.55%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 85 53 -4,701 -4,299 -4,074 -3,952 693 434 462 -321 -1,757
Operating Cash Flow to CapEx		 1,053.88% 488.57% 870.95% 885.27% 1,353.53% 726.26% 1,207.77% 1,412.80% 1,155.35% 508.57% 1,089.00%
Free Cash Flow to Firm to Interest Expense		 1.69 1.01 -77.18 -57.38 -54.97 -56.04 9.54 5.78 6.02 -3.98 -20.13
Operating Cash Flow to Interest Expense		 5.01 4.38 2.50 4.22 4.29 4.02 3.84 4.84 4.10 3.65 2.99
Operating Cash Flow Less CapEx to Interest Expense		 4.54 3.48 2.22 3.74 3.98 3.47 3.53 4.50 3.75 2.93 2.71
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.13 0.13 0.11 0.12 0.13 0.14 0.12 0.13 0.13 0.13 0.12
Fixed Asset Turnover		 0.15 0.15 0.14 0.15 0.16 0.17 0.15 0.16 0.16 0.16 0.16
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 13,697 13,801 18,355 18,022 17,805 17,774 17,720 17,628 17,397 18,150 19,483
Invested Capital Turnover		 0.14 0.14 0.13 0.14 0.15 0.15 0.14 0.14 0.14 0.14 0.14
Increase / (Decrease) in Invested Capital		 -20 15 4,678 4,327 4,108 3,973 -635 -394 -409 377 1,763
Enterprise Value (EV)		 16,271 17,319 18,987 22,316 24,534 23,149 23,461 21,431 22,874 21,223 21,743
Market Capitalization		 9,145 10,037 9,671 13,211 15,534 13,961 14,068 11,895 13,234 11,110 11,352
Book Value per Share		 $11.80 $11.61 $14.78 $12.44 $12.25 $12.01 $11.70 $11.41 $10.93 $10.79 $11.26
Tangible Book Value per Share		 $11.18 $11.03 $12.85 $10.91 $10.96 $10.84 $10.64 $10.44 $10.05 $9.75 $10.07
Total Capital		 13,697 13,801 18,355 18,022 17,805 17,774 17,720 17,628 17,397 18,150 19,483
Total Debt		 6,664 6,876 8,756 8,603 8,583 8,716 8,877 9,041 9,132 9,848 10,423
Total Long-Term Debt		 6,240 6,156 8,573 8,578 8,583 8,566 8,713 8,266 8,763 8,769 8,671
Net Debt		 6,550 6,707 8,599 8,444 8,341 8,532 8,738 8,878 8,972 9,310 9,157
Capital Expenditures (CapEx)		 24 47 18 36 24 39 23 26 27 58 24
Net Nonoperating Expense (NNE)		 -3.56 -6.67 -34 -124 -58 10 8.04 1.13 163 -66 -194
Net Nonoperating Obligations (NNO)		 6,664 6,876 8,756 8,603 8,583 8,716 8,877 9,041 9,132 9,848 10,423
Total Depreciation and Amortization (D&A)		 161 164 195 261 257 253 242 240 238 235 264
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.12 $0.13 $0.01 $0.21 $0.12 $0.02 $0.06 $0.05 ($0.17) $0.16 $0.28
Adjusted Weighted Average Basic Shares Outstanding		 547.06M 547.01M 600.90M 702.38M 699.35M 675.68M 699.07M 695.19M 694.93M 696.03M 695.16M
Adjusted Diluted Earnings per Share		 $0.12 $0.13 $0.01 $0.21 $0.12 $0.02 $0.06 $0.05 ($0.17) $0.16 $0.28
Adjusted Weighted Average Diluted Shares Outstanding		 547.33M 547.28M 601.19M 703.27M 700.15M 676.23M 699.12M 695.19M 694.93M 696.04M 695.17M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 547.07M 547.17M 703.78M 699.29M 699.44M 699.56M 694.73M 694.92M 694.95M 695.04M 689.42M
Normalized Net Operating Profit after Tax (NOPAT)		 65 46 42 36 42 36 60 53 38 62 351
Normalized NOPAT Margin		 12.77% 9.28% 7.62% 5.79% 6.70% 5.81% 9.52% 8.56% 6.11% 9.72% 52.71%
Pre Tax Income Margin		 13.32% 11.98% 4.12% 25.04% 15.73% -0.52% 8.61% 6.40% 10.37% 19.59% 29.39%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.30 1.09 -0.97 0.39 0.48 0.42 0.83 0.57 0.68 0.73 0.06
NOPAT to Interest Expense		 1.29 1.30 -0.38 0.38 0.47 0.30 0.80 0.53 0.70 0.69 0.06
EBIT Less CapEx to Interest Expense		 0.83 0.19 -1.26 -0.09 0.16 -0.13 0.51 0.23 0.33 0.01 -0.21
NOPAT Less CapEx to Interest Expense		 0.81 0.41 -0.67 -0.09 0.15 -0.26 0.48 0.19 0.34 -0.03 -0.21
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 242.08% 196.27% 310.39% 228.36% 225.60% 297.33% 275.67% 438.98% -8,392.48% 840.46% 338.21%
Augmented Payout Ratio		 244.56% 198.22% 358.66% 283.66% 282.94% 368.67% 312.78% 500.02% -9,357.35% 936.62% 367.56%

Financials Breakdown Chart

Key Financial Trends

Note: The data you provided appears to be HealthPeak Properties, Inc. (DOC) quarterly statements, not HashiCorp (HCP). If you intended HashiCorp’s data, please share the correct files and I’ll re-run the analysis specifically for HashiCorp.

  • Total revenue for the latest quarter (Q4 2025) is about $638.8 million, up modestly from $627.5 million in Q4 2024, indicating continued top-line stability.
  • Net income attributable to common shareholders in Q4 2025 was about $113.8 million, a substantial improvement versus the prior year’s period, signaling stronger profitability.
  • Earnings per share rose to $0.16 (basic and diluted) in Q4 2025, compared with around $0.02 in Q4 2024, highlighting improved profitability per share.
  • Operating cash flow from continuing activities in Q4 2025 was about $294.1 million, demonstrating solid cash generation from core operations.
  • Financing activity turned positive in Q4 2025, with net cash from continuing financing activities around $489.5 million (supported by debt issuance and repayments), indicating access to financing to support growth or liquidity needs.
  • Non-interest income remains a meaningful portion of revenue, totaling about $704.8 million in Q4 2025 (Service charges on deposits plus other non-interest income), helping diversify revenue beyond interest income.
  • The company maintains a sizable asset base (Total assets around $19.6 billion in recent quarters) and a solid equity base (Total common equity in the $7.6–8.1 billion range), suggesting a strong balance sheet footprint.
  • Quarterly results show some volatility in investing activity, with large outflows for purchases of investments in some quarters (e.g., substantial investment purchases in Q4 2025), reflecting ongoing capital allocation decisions.
  • Debt load remains material, with long-term debt around $8.8–8.8+ billion and total liabilities near $11.3 billion in recent periods, implying substantial leverage and ongoing interest expense pressure over time.
  • Investing cash outflows have been sizable across several quarters, indicating continued capital deployment into investments and property-related activities, which can weigh on near-term liquidity if financing conditions tighten.
05/07/26 05:23 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Healthpeak Properties' Financials

When does Healthpeak Properties' fiscal year end?

According to the most recent income statement we have on file, Healthpeak Properties' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has Healthpeak Properties' net income changed over the last 10 years?

Healthpeak Properties' net income appears to be on an upward trend, with a most recent value of $101.03 million in 2025, falling from -$546.42 million in 2015. The previous period was $267.30 million in 2024. Find out what analysts predict for Healthpeak Properties in the coming months.

How has Healthpeak Properties' revenue changed over the last 10 years?

Over the last 10 years, Healthpeak Properties' total revenue changed from $1.46 billion in 2015 to $2.52 billion in 2025, a change of 72.3%.

How much debt does Healthpeak Properties have?

Healthpeak Properties' total liabilities were at $12.03 billion at the end of 2025, a 10.6% increase from 2024, and a 2.8% increase since 2015.

How much cash does Healthpeak Properties have?

In the past 10 years, Healthpeak Properties' cash and equivalents has ranged from $44.23 million in 2020 to $467.46 million in 2025, and is currently $467.46 million as of their latest financial filing in 2025.

How has Healthpeak Properties' book value per share changed over the last 10 years?

Over the last 10 years, Healthpeak Properties' book value per share changed from 20.09 in 2015 to 10.79 in 2025, a change of -46.3%.


Related Companies

Financial statements for NYSE:DOC last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel